ACE2 and breast carcinoma: As shown in Fig. 9E, in breast cancer patients receiving chemotherapy, high ACE2 expression was associated with poorer overall survival, whereas ACE2 expression was not significantly associated with overall survival in patients who did not receive chemotherapy.